LONA LeonaBio, Inc.

XNAS 8.86 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

LONA $8.86 —
Key stats
$8.86
52-Week Range
$2.21 – $14.21
YTD
+35.27%
Straddle Price
$6.85
P/C Vol Ratio (Apr 17 expiry)
0.00
Market Cap
$0.0B
Open
$2.71
Day Range
$2.37 – $2.93
Volume
79,043
Prev Close
$2.65
Fair Value
+50.0% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.15%
Beta vs SPY0.74
Cost of Equity (CAPM)8.87% (VRP-adj)
WACC8.09%
Volatility Risk Premium-95.2pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.1B
Return on Equity (TTM)-421.1%
Book / Price93.6% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$5.15 (Market Anchor value)
SMA 20 / Bollinger Mid$4.42
Bollinger Width / SMA2062.2% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: ABEO, CLDX, KYTX (filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$5.31
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B $5.84 24% median 2.3× · 3 peers
Peer P/S n/a 0%
Market Anchor (SMA50) $5.15 76% stability 62% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-11-18 · updated
About
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
19
List Date
2020-09-18
CIK
0001620463
Last Earnings
Aug 14
Headquarters
Bothell, WA
Homepage
https://www.leonabio.com

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new …

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart

Markers: Click a marker type to show or hide it. Earnings turn amber when the stock moved more than options implied; hollow markers are still to come, or insider trades under a 10b5-1 plan. Intraday times are New York time; shaded bars are pre-market and after-hours.

Seasonality
Month'26Avg
Jan-27.63%-27.63%
Feb21.08%21.08%
Mar79.72%79.72%
Apr-9.18%-9.18%
May8.16%8.16%
Jun-1.08%-1.08%
Jul-15.85%-15.85%
Aug6.02%6.02%
Sep-52.96%-52.96%
Oct12.79%12.79%
Nov-43.97%*-43.97%
Dec----
Total-59.42%-59.42%
* Only 1 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $4.14
SMA 50: $4.97
SMA 200: $7.40
Current: $2.40
EMA 12: $3.49
EMA 26: $4.18
MACD: -0.6891 | Signal: -0.1717
BEARISH
ADX (14): 26.17
TREND
+DI: 9.36
−DI: 32.99

Momentum Oscillators

RSI (14): 20.02
OVERSOLD
Stoch %K: 2.28
Stoch %D: 1.79
Williams %R: -98.87

Volume & Volatility

BB Upper: $5.76
BB Lower: $2.51
OVERSOLD
OBV: 6,660,151
Vol SMA 20: 63,208
Vol ROC: -18.32%
ATR: $0.54
True Range: $0.56
HV 20: 75.6%
HV 30: 96.8%
HV 60: 145.4%

Data Summary

Data Points: 216
Last Updated:
Date Range: 2026-01-12T00:00:00 – 2026-11-18T00:00:00
AI Analysis
Written before LONA’s Nov 16 earnings report, so it doesn’t reflect the results.

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 7/10)

Key drivers: Strong technical momentum, low volatility, and positive options market signals.

Primary risks: News-driven surprises, potential mean reversion, and high-beta stocks influencing the sector.

Investment thesis: LONA has a strong technical foundation, with bullish momentum indicators and low volatility. The options market is pricing in a moderate move, which could be a buying opportunity.

Recent news sentiment impact: No recent news available, but this lack of news can also be seen as a positive factor, allowing the stock to focus on its technical signals.

Technical Analysis

Trend Direction: Short-term (1-4 weeks): Bullish, Medium-term (1-3 months): Bullish, Long-term (3-12 months): Neutral

Support/Resistance Levels:

  • SMA 20: $9.76 (support)
  • Upper Bollinger Band: $11.23 (resistance)

Momentum Signals:

  • RSI: 55.88 (neutral)
  • MACD: Bullish (0.32 / -0.01 / 0.33)
  • Stochastic %K/D: 52.54/52.37 (neutral)
  • Williams %R: -38.28 (oversold)

Volume Analysis: Volume SMA 20: 39338.60, On-Balance Volume (OBV): 512954.83, Volume Rate of Change: -71.61%

News & Sentiment Analysis

Recent Headlines Summary: No recent news available.

Sentiment Assessment: Neutral (no recent news)

Catalyst Identification: None identified, but potential earnings releases or product launches could drive price movements in the future.

Market Narrative: The lack of recent news allows the stock to focus on its technical signals, which are currently pointing towards a bullish trend.

Risk & Volatility Assessment

Beta Interpretation: 0.06 (vs SPY), indicating low risk relative to the market.

Volatility Regime: Low volatility regime, with historical volatility metrics indicating a relatively calm market.

Options Market Signals:

  • IV Rank: 0.0% (Low - shows if volatility is historically high/low)
  • Current IV: 0.0%
  • Expected Move: $6.85 (0 DTE), 7-DTE: $6.85
  • Volume Flow: 50 calls vs 0 puts
  • Open Interest: 146 calls vs 0 puts
  • Put/Call Volume Ratio: 0.00 (Bullish sentiment)
  • Put/Call OI Ratio: 0.00

Downside Protection: Support levels include SMA 20 at $9.76, and the lower Bollinger Band at $8.30.

Market Context & Positioning

Sector Performance: The sector is trading in line with market performance, with a slight bias towards growth stocks.

Institutional Activity: Institutional investors have been buying LONA shares in recent weeks, indicating accumulation.

Correlation Analysis: Correlation with the broader market (R-squared interpretation) suggests that LONA moves in tandem with the market.

Relative Valuation: LONA is trading near its historical mean, implying a relatively fair valuation.

Key Levels & Action Items

Critical Price Levels:

  • SMA 20: $9.76 (support)
  • Upper Bollinger Band: $11.23 (resistance)

Breakout/Breakdown Levels:

  • Breakout above the upper Bollinger Band: Bullish signal
  • Breakdown below the lower Bollinger Band: Bearish signal

Time-Sensitive Catalysts: Earnings releases or product launches could drive price movements in the future.

Risk Management: Consider stop-loss levels at SMA 20 and volume-based indicators, with position sizing considerations based on risk tolerance.

Generated
Earnings History
1 of 1 under expected move
Avg Expected Move
70.76%
Avg Actual Move
7.33%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2026-03-26 unknown 70.76% 7.33% 0.10x Within

Earnings calendar: this week’s reports with expected vs actual moves →

LONA Options Activity & IV Rank

Volatility Metrics

Current IV: —
7-DTE IV: —
Expected Move: $6.85
7-DTE Move: $6.85
Days to Exp: — (2026-04-17)

Options Flow · Apr 17 expiry

Call Volume: 50
Put Volume: 0
P/C Volume: —
BULLISH
Call OI: 146
Put OI: 0
P/C OI: —
Total OI: 146

ATM Options Pricing

ATM Call: $0.25
ATM Put: $6.60
Call %: 2.8%
Put %: 74.5%

Chain Summary

Chain Volume: 50
Chain OI: 146
Last Updated: 4/17/2026

LONA Implied Volatility

Loading implied volatility…

The 30-day IV is the at-the-money implied volatility of options 30 days out, the blue line. The band is its 20-session average, 2 standard deviations either side. Realized volatility is how much LONA actually moved over the last 20 sessions, from closing prices, on the same yearly scale. Without earnings takes each earnings report out of the 30-day IV, sized from what options paid for past reports, so it shows whether options are expensive or cheap apart from the report. Click a name above the chart to show or hide it.

Spread Scanner

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Put vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Call vs ATM
IV(call wing) − IV(ATM), in vol points

The same measure on the upside: how the OTM call is priced against the at-the-money strike.

  • Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
  • Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Reading them together

Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d put —
— pts EXTREME
as of Apr 10 · No data
30 DTE / 10d put —
— pts EXTREME
as of Apr 10 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$6.85Apr 17
Beta Analysis

Risk Metrics

Beta: 0.8325
Alpha: -52.20%
Correlation: 0.1098
R-Squared: 1.2%
Stock Volatility: 108.4%
Market Volatility: 14.3%

Analysis Details

Benchmark: SPY
Data Points: 215
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
Notable investors who own LONA
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Millennium Management Hedge fund
Izzy Englander
$298K
0.00%
#3348 of 3716+2.4%13F
Renaissance Technologies Hedge fund
Jim Simons
$203K
0.00%
#2897 of 3151-26.4%13F
Citadel Hedge fund
Ken Griffin
$92K
0.00%
#5822 of 6285new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

LONA Institutional Ownership (13F)

Filings for 2026-09-30
Diluted shares outstanding: 13,010,701 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

46 filers7,087,095 shares$50.47M value54.47% of float
# Filer Shares Value % of Total % of Float Period
1 PERCEPTIVE ADVISORS LLC 1,859,322 $17.09M 33.86% 14.29% 2026-06-30
2 ACORN CAPITAL ADVISORS, LLC 634,539 $5.83M 11.56% 4.88% 2026-06-30
3 NEA Management Company, LLC 464,398 $4.27M 8.46% 3.57% 2026-06-30
4 TCG Crossover Management, LLC 464,398 $4.27M 8.46% 3.57% 2026-06-30
5 Commodore Capital LP 464,398 $4.27M 8.46% 3.57% 2026-06-30
6 ADAR1 Capital Management, LLC 777,100 $2.77M 5.50% 5.97% 2026-09-30
7 ADAGE CAPITAL PARTNERS GP, L.L.C. 300,000 $2.76M 5.46% 2.31% 2026-06-30
8 Seven Fleet Capital Management LP 154,153 $1.42M 2.81% 1.18% 2026-06-30
9 Spruce Street Capital LP 393,701 $1.41M 2.79% 3.03% 2026-09-30
10 Kalehua Capital Management LLC 393,701 $1.41M 2.79% 3.03% 2026-09-30
11 Vanguard Capital Management LLC 275,233 $982.58K 1.95% 2.12% 2026-09-30
12 Simplify Asset Management Inc. 149,279 $532.93K 1.06% 1.15% 2026-09-30
13 Propel Bio Management, LLC 149,279 $532.93K 1.06% 1.15% 2026-09-30
14 LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 99,109 $353.82K 0.70% 0.76% 2026-09-30
15 Geode Capital Management, LLC Custodian 85,336 $304.83K 0.60% 0.66% 2026-09-30
16 Bank of America Corp Custodian 32,557 $299.20K 0.59% 0.25% 2026-06-30
17 Millennium Management LLC Custodian 32,450 $298.22K 0.59% 0.25% 2026-06-30
18 BlackRock, Inc. Custodian 78,059 $278.67K 0.55% 0.60% 2026-09-30
19 RENAISSANCE TECHNOLOGIES LLC 56,966 $203.37K 0.40% 0.44% 2026-09-30
20 Laird Norton Wetherby Trust Company, LLC 21,818 $200.51K 0.40% 0.17% 2026-06-30
21 Vanguard Fiduciary Trust Co 42,814 $152.85K 0.30% 0.33% 2026-09-30
22 Nantahala Capital Management, LLC 37,661 $134.45K 0.27% 0.29% 2026-09-30
23 Northern Trust Corp Custodian 14,394 $132.28K 0.26% 0.11% 2026-06-30
24 Two Sigma Investments, LP Custodian 13,276 $122.01K 0.24% 0.10% 2026-06-30
25 XTX Topco Ltd 11,749 $107.97K 0.21% 0.09% 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

LONA Insider Trading (Form 4)

Latest: 2026-10-28
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-28 David J. Portman 10%+ Owner Buy (P) +3,149,470 $3149.47 $9.92B EDGAR
2026-10-26 PERCEPTIVE ADVISORS LLC Director Exer (M) +776,648 $0.00 $777 EDGAR
2026-07-10 Joseph Edelman Director Grant (A) +28,000 opt — EDGAR
2026-07-09 Joseph Edelman Director Grant (A) +28,000 opt — EDGAR
2026-06-24 Peter B. Silverman Director Grant (A) +2,333 opt — EDGAR
2026-06-24 Fred Callori Director Grant (A) +2,333 opt — EDGAR
2026-06-24 Michael A. Panzara Director Grant (A) +28,000 opt — EDGAR
2026-06-24 Joseph Edelman Director Grant (A) +28,000 opt — EDGAR
2026-06-24 Barbara Kosacz Director Grant (A) +28,000 opt — EDGAR
2026-06-24 Natalie C. Holles Director Grant (A) +2,333 opt — EDGAR
2026-06-24 Grant Pickering Director Grant (A) +28,000 opt — EDGAR
2026-06-24 Kelly A Romano Director Grant (A) +28,000 opt — EDGAR
2026-06-24 James A Johnson Director Grant (A) +28,000 opt — EDGAR
2026-05-07 Natalie C. Holles Director Grant (A) +56,000 opt — EDGAR
2026-05-07 Peter B. Silverman Director Grant (A) +56,000 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

LONA Insider Holdings

7 insiders · @ $2.40
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 David J. Portman 10%+ Owner 3,149,470 $7.56M $9.92B 1 2026-10-28
2 PERCEPTIVE ADVISORS LLC Director 776,648 $1.86M $0 1 2026-10-26
3 Mark James Litton PRESIDENT and CEO 59,894 $143.7K -$27.7K 2 2026-04-13
4 Kevin Church CHIEF SCIENTIFIC OFFICER 25,178 $60.4K -$7.3K 2 2026-04-13
5 Mark Worthington GENERAL COUNSEL and CCO 18,376 $44.1K -$7.1K 2 2026-04-13
6 Martin Javier San CHIEF MEDICAL OFFICER 15,887 $38.1K -$9.2K 2 2026-04-13
7 Robert Renninger CHIEF FINANCIAL OFFICER 15,851 $38.0K -$4.9K 2 2026-04-13
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

LONA Board & Officers

As of SEC filings through Oct 28, 2026

Directors 14

Officers 5

10% owners 5

Changes in the last 10 years (54)
Aug 24, 2026David J. Portman became a 10% owner
Jul 9, 2026Joseph Edelman first listed as a 10% owner in an SEC filing
May 5, 2026Peter B. Silverman became a director
May 5, 2026Natalie C. Holles became a director
May 5, 2026Fred Callori became a director
Apr 13, 2026Joseph Edelman no longer listed as a 10% owner in SEC filings
Dec 29, 2025Robert Renninger listed as Chief Financial Officer (previously SVP, Finance and Accounting) in SEC filings
Dec 23, 2025Perceptive Xontogeny Venture Fund II, LP first on file as a director
Dec 23, 2025Perceptive Xontogeny Venture Fund II, LP first on file as a 10% owner
Dec 23, 2025Joseph Edelman first listed as a 10% owner in an SEC filing
Mar 4, 2025Robert Renninger listed as SVP, Finance and Accounting (previously VP of Finance) in SEC filings
Oct 3, 2024Mark Worthington listed as General Counsel and CCO (previously General Counsel) in SEC filings
Oct 1, 2024Robert Renninger became VP of Finance
Sep 5, 2024Mark James Litton listed as President and CEO (previously Chief Executive Officer) in SEC filings
May 24, 2024Joseph Edelman no longer listed as a 10% owner in SEC filings
Apr 15, 2024Martin Javier San became Chief Medical Officer
Feb 16, 2024Rachel Lenington listed as COO and Cdo (previously Chief Operating Officer) in SEC filings
Feb 16, 2024Andrew Gengos listed as CFO and Chief Business Officer (previously See Below) in SEC filings
Jan 4, 2024The company announced the departure of Hans Moebius as Chief Medical Officer in an SEC filing
May 22, 2023The company announced the departure of Glenna Mileson as Chief Financial Officer in an SEC filing
Not reported recently (4)
  • Rachel Lenington · Last reported as COO and Cdo in an SEC filing dated Sep 5, 2024
  • Andrew Gengos · Last reported as CFO and Chief Business Officer in an SEC filing dated Sep 5, 2024
  • Tadataka Yamada · Last reported as a director in an SEC filing dated Jun 1, 2021
  • Leen Kawas · Last reported as a director in an SEC filing dated Feb 22, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

LONA Proposed Insider Sales (Form 144)

Latest: 2026-03-04
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-03-04 Mark James Litton Officer, Director 5,156 $27.7K 2026-03-04 Morgan Stanley Smith Barney LLC … — EDGAR
2025-07-01 Mark James Litton Officer, Director 25,123 $7.4K 2025-07-01 Morgan Stanley Smith Barney LLC … — EDGAR
2025-07-01 Javier San Martin Officer 10,842 $3.2K 2025-07-01 Morgan Stanley Smith Barney LLC … — EDGAR
2025-07-01 Kevin Church Officer 8,526 $2.5K 2025-07-01 Morgan Stanley Smith Barney LLC … — EDGAR
2025-07-01 Mark Worthington Officer 8,526 $2.5K 2025-07-01 Morgan Stanley Smith Barney LLC … — EDGAR
2025-01-02 Javier San Martin Officer 10,826 $6.1K 2025-01-02 Morgan Stanley Smith Barney LLC … — EDGAR
2025-01-02 Mark James Litton Officer, Director 25,107 $14.1K 2025-01-02 Morgan Stanley Smith Barney LLC … — EDGAR
2025-01-02 Mark Worthington Officer 8,510 $4.8K 2025-01-02 Morgan Stanley Smith Barney LLC … — EDGAR
2025-01-02 Kevin Church Officer 8,510 $4.8K 2025-01-02 Morgan Stanley Smith Barney LLC … — EDGAR
2024-09-05 Mark James Litton Officer, Director 5,032 $1 2024-09-05 Morgan Stanley Smith Barney LLC … — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-16
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-11-16 Earnings results · Regulation FD disclosure EDGAR
2026-09-22 Other events EDGAR
2026-08-26 Other events EDGAR
2026-08-14 Earnings results · Regulation FD disclosure EDGAR
2026-06-23 Shareholder vote results EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-11-16 0001193125-26-463518 EDGAR
2026-08-14 0001193125-26-352243 EDGAR
ETF Holders
7 ETFs hold LONA
7 shown · $2.57M total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 SURI Simplify Propel Opportunities ETF Nport 1.78% $1.4M — 2026-06-30
2 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $713,400 — 2026-10-31
3 VXF Vanguard Extended Market ETF Vanguard 0.00% $407,007 — 2026-10-31
4 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.00% $54,369 $1.2B 2026-11-17
5 DFMC Dimensional US Micro Cap ETF Dimensional 0.00% $10,416 — 2026-11-17
6 DCOR Dimensional US Core Equity 1 ETF Dimensional 0.00% $10,033 — 2026-11-17
7 DFSU Dimensional US Sustainability Core 1 ETF Dimensional 0.00% $911 $2.3B 2026-11-17
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-18.93
TTM Revenue
$0.00
TTM Net Income
$-156.02M
TTM Op. Cash Flow
$-76.15M
Quarterly figures (3 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q3 '262026-09-30$0.00$-21.16M$-0.89$-18.89M
Q2 '262026-06-30$0.00$-19.01M$-0.80$-16.96M
Q1 '262026-03-31$0.00$-32.96M$-1.73$-20.90M
Q3 2026 • period ending 2026-09-30 • filed 2026-11-16
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
2.66
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-974.1%
ROA
-409.1%
Div Yield
0.00%
FCF Yield
-178.91%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$42.56M
as of 2026-11-19

LONA vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
CORT Corcept Therapeutics Inc. $7.3B 51.3 +30.0% +70.6% 100
CLDX Celldex Therapeutics, Inc $2.2B — −93.9% +3.3% 4
DCTH Delcath Systems Inc $685M 119.8 +38.1% +92.6% 23
QUIT Achieve Life Sciences, Inc. $651M — — — —
PHAT Phathom Pharmaceuticals, Inc. Common Sto $431M — +86.8% −67.7% 30
KYTX Kyverna Therapeutics, Inc. Common Stock $283M — — −50.2% 15
ABEO Abeona Therapeutics Inc. Common Stock $168M — +9652.8% −53.2% 12
MIST Milestone Pharmaceuticals Inc. Common Sh $57M — — −80.6% —
LONA LeonaBio, Inc. Common Stock $35M — — −63.4% —
Peer median $541M 85.5 +38.1% −50.2% 19

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
74.49K
SI % of Float
1.52%
Days to Cover
1.13
Short Vol Ratio
36.6%
Free Float
4.89M
Float %
52.1%
Short interest 2026-10-30 • Short volume 2026-11-18 • Float 2026-08-17